BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21957314)

  • 1. Efficiency of neutralizing antibodies targeting the CD4-binding site: influence of conformational masking by the V2 loop in R5-tropic clade C simian-human immunodeficiency virus.
    Watkins JD; Diaz-Rodriguez J; Siddappa NB; Corti D; Ruprecht RM
    J Virol; 2011 Dec; 85(23):12811-4. PubMed ID: 21957314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity.
    Choi WS; Collignon C; Thiriart C; Burns DP; Stott EJ; Kent KA; Desrosiers RC
    J Virol; 1994 Sep; 68(9):5395-402. PubMed ID: 7520089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.
    Hu G; Liu J; Roux KH; Taylor KA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.
    Tasca S; Ho SH; Cheng-Mayer C
    J Virol; 2008 Jul; 82(14):7089-99. PubMed ID: 18480460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.
    Pikora C; Wittish C; Desrosiers RC
    J Virol; 2005 Oct; 79(19):12575-83. PubMed ID: 16160185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
    Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
    Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses.
    Kuwata T; Takaki K; Yoshimura K; Enomoto I; Wu F; Ourmanov I; Hirsch VM; Yokoyama M; Sato H; Matsushita S
    J Virol; 2013 May; 87(10):5424-36. PubMed ID: 23468483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.
    Falkowska E; Ramos A; Feng Y; Zhou T; Moquin S; Walker LM; Wu X; Seaman MS; Wrin T; Kwong PD; Wyatt RT; Mascola JR; Poignard P; Burton DR
    J Virol; 2012 Apr; 86(8):4394-403. PubMed ID: 22345481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding.
    Finzi A; Pacheco B; Xiang SH; Pancera M; Herschhorn A; Wang L; Zeng X; Desormeaux A; Kwong PD; Sodroski J
    J Virol; 2012 Sep; 86(17):8974-86. PubMed ID: 22696649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein.
    Javaherian K; Langlois AJ; Montefiori DC; Kent KA; Ryan KA; Wyman PD; Stott J; Bolognesi DP; Murphey-Corb M; Larosa GJ
    J Virol; 1994 Apr; 68(4):2624-31. PubMed ID: 7511176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography.
    White TA; Bartesaghi A; Borgnia MJ; de la Cruz MJ; Nandwani R; Hoxie JA; Bess JW; Lifson JD; Milne JL; Subramaniam S
    J Virol; 2011 Dec; 85(23):12114-23. PubMed ID: 21937655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A; Stamatatos L
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
    Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
    J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity.
    Puffer BA; Pöhlmann S; Edinger AL; Carlin D; Sanchez MD; Reitter J; Watry DD; Fox HS; Desrosiers RC; Doms RW
    J Virol; 2002 Mar; 76(6):2595-605. PubMed ID: 11861825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.
    Glamann J; Burton DR; Parren PW; Ditzel HJ; Kent KA; Arnold C; Montefiori D; Hirsch VM
    J Virol; 1998 Jan; 72(1):585-92. PubMed ID: 9420262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.
    Kilgore KM; Murphy MK; Burton SL; Wetzel KS; Smith SA; Xiao P; Reddy S; Francella N; Sodora DL; Silvestri G; Cole KS; Villinger F; Robinson JE; Pulendran B; Hunter E; Collman RG; Amara RR; Derdeyn CA
    J Virol; 2015 Aug; 89(16):8130-51. PubMed ID: 26018167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner.
    Saunders CJ; McCaffrey RA; Zharkikh I; Kraft Z; Malenbaum SE; Burke B; Cheng-Mayer C; Stamatatos L
    J Virol; 2005 Jul; 79(14):9069-80. PubMed ID: 15994801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
    O'Connell O; Repik A; Reeves JD; Gonzalez-Perez MP; Quitadamo B; Anton ED; Duenas-Decamp M; Peters P; Lin R; Zolla-Pazner S; Corti D; Wallace A; Wang S; Kong XP; Lu S; Clapham PR
    J Virol; 2013 Jan; 87(1):187-98. PubMed ID: 23055568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.
    Kent KA; Rud E; Corcoran T; Powell C; Thiriart C; Collignon C; Stott EJ
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1147-51. PubMed ID: 1380261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.